High altitude cerebral edema: Difference between revisions
Neil.m.young (talk | contribs) No edit summary |
Neil.m.young (talk | contribs) No edit summary |
||
| Line 19: | Line 19: | ||
*Hyponatremia | *Hyponatremia | ||
== | ==Management== | ||
#Immediate descent is the treatment of choice | #Immediate descent is the treatment of choice | ||
#If descent not possible use combination of: | #If descent not possible use combination of: | ||
# | #*Supplemental O2 (goal SpO2 90%)<ref>Hackett PH, Roach RC. High altitude cerebral edema. High Alt Med Biol 2004; 5:136-146.</ref> | ||
# | #*Dexamethasone 8mg initially, then 4mg q6hr | ||
# | #*Acetazolamide 250 mg BID (better as ppx) | ||
# | #*Hyperbaric bag if available | ||
==Prevention== | ==Prevention== | ||
Revision as of 22:36, 23 February 2016
Background
- Also known as HACE
- Progressive neurologic deterioration in someone with AMS or HAPE (due to incr ICP)
- Almost never occurs at <8000ft
Clinical Features
- Altered mental status, ataxia, gait disturbance, stupor (most sensitive findings)
- Progresses to coma if untreated
- Headache, nausea, and vomiting are not always present
- Focal neuro deficits may be seen (3rd/6th CN palsies)
- Seizures are rare
Differential Diagnosis
High Altitude Illnesses
- Acute mountain sickness
- Chronic mountain sickness
- High altitude cerebral edema
- High altitude pulmonary edema
- High altitude peripheral edema
- High altitude retinopathy
- High altitude pharyngitis and bronchitis
- Ultraviolet keratitis
- Dehydration
- Exhaustion
- Hypoglycemia
- Hypothermia
- Hyponatremia
Management
- Immediate descent is the treatment of choice
- If descent not possible use combination of:
- Supplemental O2 (goal SpO2 90%)[1]
- Dexamethasone 8mg initially, then 4mg q6hr
- Acetazolamide 250 mg BID (better as ppx)
- Hyperbaric bag if available
Prevention
- Acetazolamide 125mg BID (250mg BID if greater than 100kg)
- Dexamethasone 4mg q6h PO or IV
See Also
References
- ↑ Hackett PH, Roach RC. High altitude cerebral edema. High Alt Med Biol 2004; 5:136-146.
